Literature DB >> 19172270

The European searchable tumour line database.

James Robinson1, Chrissy H Roberts, I Anthony Dodi, J Alejandro Madrigal, Graham Pawelec, Lilly Wedel, Steven G E Marsh.   

Abstract

The European Searchable Tumour line Database (ESTDAB) ( http://www.ebi.ac.uk/ipd/estdab ) is a freely available and fully searchable database of melanoma-derived cell lines, which have been characterised for over 250 immunologically relevant markers by a consortium of European scientists. The database is linked to a cell bank, which can provide melanoma cell lines to non-profit investigators for a nominal handling charge. All cells are fully HLA typed at the genomic and surface expression levels. The expression of a number of surface antigens, apoptotic markers, tumour-associated antigens and extracellular matrix proteins has also been determined. Cytokine secretion has been tested and polymorphisms in cytokine genes have been identified. Glycans at the cell surface were identified and glycosyltransferase activity quantified. Cell lines with a particular constellation of these parameters can be sought online via the ESTDAB interface, which is included as part of the Immuno-Polymorphism Database (IPD) section of the European Bioinformatics Institute's (EBI) website.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19172270     DOI: 10.1007/s00262-008-0656-5

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  8 in total

1.  Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.

Authors:  Braslav Jovanovic; Suzanne Egyhazi; Malihe Eskandarpour; Paola Ghiorzo; Jane M Palmer; Giovanna Bianchi Scarrà; Nicholas K Hayward; Johan Hansson
Journal:  J Invest Dermatol       Date:  2009-09-17       Impact factor: 8.551

2.  The IPD and IMGT/HLA database: allele variant databases.

Authors:  James Robinson; Jason A Halliwell; James D Hayhurst; Paul Flicek; Peter Parham; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

3.  Bioenergetic modulation with dichloroacetate reduces the growth of melanoma cells and potentiates their response to BRAFV600E inhibition.

Authors:  Cecilie Abildgaard; Christina Dahl; Astrid L Basse; Tao Ma; Per Guldberg
Journal:  J Transl Med       Date:  2014-09-03       Impact factor: 5.531

4.  Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells.

Authors:  Cecilie Abildgaard; Christina Dahl; Ahmad Abdul-Al; Annette Christensen; Per Guldberg
Journal:  Oncotarget       Date:  2017-08-24

Review 5.  The IPD Project: a centralised resource for the study of polymorphism in genes of the immune system.

Authors:  Giuseppe Maccari; James Robinson; John A Hammond; Steven G E Marsh
Journal:  Immunogenetics       Date:  2019-10-22       Impact factor: 2.846

6.  IPD--the Immuno Polymorphism Database.

Authors:  James Robinson; Kavita Mistry; Hamish McWilliam; Rodrigo Lopez; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2009-10-29       Impact factor: 16.971

7.  IPD--the Immuno Polymorphism Database.

Authors:  James Robinson; Jason A Halliwell; Hamish McWilliam; Rodrigo Lopez; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

8.  Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma.

Authors:  Cecilie Abildgaard; Salvatore Rizza; Helle Christiansen; Steffen Schmidt; Christina Dahl; Ahmad Abdul-Al; Annette Christensen; Giuseppe Filomeni; Per Guldberg
Journal:  Sci Rep       Date:  2021-02-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.